Literature DB >> 23338245

[Magnetic resonance imaging of hypertrophic cardiomyopathy : evaluation of diastolic function].

F Schwarz1, F Schwab, B M Beckmann, F Schuessler, D Zinsser, T Gölz, S Kääb, M F Reiser, D Theisen.   

Abstract

Hypertrophic cardiomyopathy (HCM) has a prevalence of approximately 0.2% and is clinically asymptomatic in many patients or presents with unspecific symptoms. This explains the importance of imaging for the diagnosis of HCM as well as for the assessment of the clinical course. The definitive finding in HCM is myocardial hypertrophy with thickening of the ventricular wall ≥ 15 mm. While echocardiography is an excellent screening tool magnetic resonance imaging (MRI) allows a comprehensive analysis of the heart in HCM. This includes a detailed analysis of the distribution and extent of myocardial hypertrophy, a thorough evaluation of systolic and diastolic cardiac function, the assessment of the presence and extent of dynamic outflow tract obstruction as well as the description of the systolic anterior motion (SAM) phenomenon of the mitral valve with secondary mitral insufficiency. When contrast material is administered, additional information about myocardial perfusion as well as the presence and extent of myocardial fibrosis can be obtained. This study compared systolic functional parameters as well as end systolic and end diastolic wall thickness of patients with and without diastolic dysfunction.

Entities:  

Mesh:

Year:  2013        PMID: 23338245     DOI: 10.1007/s00117-012-2381-5

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  30 in total

1.  [Cardiovascular whole-body MRI: possibilities and limitations in prevention].

Authors:  C U Herborn; F M Vogt; M Goyen; S C Goehde; S G Ruehm; M Forsting
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

2.  Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.

Authors:  Kunihiko Teraoka; Masaharu Hirano; Hiroyuki Ookubo; Kazuyoshi Sasaki; Hiroaki Katsuyama; Masayuki Amino; Yimihiko Abe; Akira Yamashina
Journal:  Magn Reson Imaging       Date:  2004-02       Impact factor: 2.546

3.  Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy.

Authors:  J A Panza; R K Petrone; L Fananapazir; B J Maron
Journal:  J Am Coll Cardiol       Date:  1992-01       Impact factor: 24.094

4.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

5.  Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy.

Authors:  R Thaman; J R Gimeno; R T Murphy; T Kubo; B Sachdev; J Mogensen; P M Elliott; W J McKenna
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

6.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

7.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

8.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

Review 9.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

10.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Authors:  A Pelliccia; B J Maron; A Spataro; M A Proschan; P Spirito
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

View more
  2 in total

Review 1.  Value of electro-vectorcardiogram in hypertrophic cardiomyopathy.

Authors:  Andrés Ricardo Pérez-Riera; Augusto Armando de Lucca; Raimundo Barbosa-Barros; Frank G Yanowitz; Silvia Fortunato de Cano; Manuel Nicolás Cano; Antônio Carlos Palandri-Chagas
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-07       Impact factor: 1.468

Review 2.  Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.

Authors:  Diogo Costa Leandro de Oliveira; Fernanda Boldrini Assunção; Alair Agusto Sarmet Moreira Damas Dos Santos; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2016-06-10       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.